Recruiting Evaluating Buspirone to Treat Opioid Withdrawal NCT05511909 Conditions Anxiety, Anxiety Disorders, Chemically-Induced Disorders, +7 more Locations Kahlert Institute for Addictino Medicin — Baltimore, Maryland, United States View Trial Details
Recruiting Assessing a Clinically-meaningful Opioid Withdrawal Phenotype NCT05027919 Conditions Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more Locations University of Maryland — Baltimore, Maryland, United States View Trial Details
Completed Developing a Clinical Outcome Assessment for Opioid Craving NCT05109429 Conditions Chemically-Induced Disorders, Measure Development, Mental Disorders, +5 more Locations Behavioral Pharmacology Research Unit — Baltimore, Maryland, United States View Trial Details
Completed Evaluating the Feasibility, Acceptability, and Preliminary Outcomes of Heart Rate Variability Biofeedback for Individuals With Opioid Use Disorder. NCT07361731 Conditions Autonomic Nervous System Imbalance, Behavior, Biofeedback, +15 more Locations Arizona State University — Phoenix, Arizona, United States View Trial Details
Completed Oral Cannabidiol for Opioid Withdrawal NCT04238754 Conditions Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more Locations Johns Hopkins University — Baltimore, Maryland, United States View Trial Details
